Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood

被引:29
作者
Borthakur, G
Cruz, MA
Dong, JF
McIntire, L
Li, F
López, JA
Thiagarajan, P
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Hematol, Houston, TX USA
[2] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[4] Rice Univ, Cox Lab Biomed Engn, Houston, TX 77251 USA
关键词
glycoprotein Ib; sulfatides; von Willebrand factor;
D O I
10.1046/j.1538-7836.2003.00156.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sulfatides are sulfated glycosphingolipids present on cell surfaces that bind to adhesive proteins such as von Willebrand factor (VWF), P-selectin, laminin and thrombospondin. Previous Studies have localized the sulfatide-binding site of VWF to amino acid residues Gln626-Val646 in the At domain. The A1 domain also contains the binding site for platelet glycoprotein Ib (GP Ib), a site that has been reported to be distinct from the sulfatide-binding site. In this study, we analyzed the interaction of sulfatides with VWF and its effect on GP Ib-mediated platelet adhesion under flow conditions. Recombinant VWF A I domain (rVWF-A1) bound specifically and saturably to sulfatides (half-maximal concentration of similar to 12.5 mug mL(-1)), binding that was blocked by dextran sulfate (IC50 approximate to 100 mug mL(-1)) but not by heparin at concentrations up to 100 U mL(-1). Furthermore, sulfatides (125 mug mL(-1)) prevented the adhesion of platelets or glycocalicin-coupled polystyrene beads to a rVWF-A1-coated surface under high shear stress. In addition, plasma VWF prebound to a sulfatide-coated surface failed to support subsequent platelet adhesion. These results provide firm evidence that sulfatides bind the VWFA1 domain at a site overlapping the GP Ib-binding site.
引用
收藏
页码:1288 / 1295
页数:8
相关论文
共 34 条
[21]   Role for sulfatides in platelet aggregation [J].
Merten, M ;
Thiagarajan, P .
CIRCULATION, 2001, 104 (24) :2955-2960
[22]  
MOHRI H, 1989, J BIOL CHEM, V264, P17361
[23]  
MOHRI H, 1988, J BIOL CHEM, V263, P17901
[24]   STUDIES ON FACTOR-VIII-RELATED PROTEIN .2. ESTIMATION OF MOLECULAR-SIZE DIFFERENCES BETWEEN FACTOR-VIII OLIGOMERS [J].
PERRET, BA ;
FURLAN, M ;
BECK, EA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 578 (01) :164-174
[25]  
PIETU G, 1989, BIOCHEM BIOPH RES CO, V164, P1339
[26]  
ROBERTS DD, 1986, J BIOL CHEM, V261, P6872
[27]  
ROBERTS DD, 1986, J BIOL CHEM, V261, P3306
[28]   VARIANT VONWILLEBRANDS DISEASE - CHARACTERIZATION OF 2 SUBTYPES BY ANALYSIS OF MULTIMERIC COMPOSITION OF FACTOR 8 VONWILLEBRAND-FACTOR IN PLASMA AND PLATELETS [J].
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (06) :1318-1325
[29]   STRUCTURE AND IMMUNOLOGICAL LOCALIZATION OF SPLEEN SULFOLIPID [J].
SARLIEVE, LL ;
ZALC, B ;
NESKOVIC, NM ;
ZANETTA, JP ;
REBEL, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (01) :166-168
[30]   CDNA SEQUENCES FOR HUMAN VONWILLEBRAND-FACTOR REVEAL 5 TYPES OF REPEATED DOMAINS AND 5 POSSIBLE PROTEIN-SEQUENCE POLYMORPHISMS [J].
SHELTONINLOES, BB ;
TITANI, K ;
SADLER, JE .
BIOCHEMISTRY, 1986, 25 (11) :3164-3171